Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 18.00 is 15% above its 1-year average of 15.62, near the high end of its 1-year range (13.24–18.00).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly quick ratio; no daily interpolation.
Limited quarterly history available
Quick Ratio needs at least three reported quarters before a meaningful chart is shown.
QUICK RATIO (ACID-TEST)
18.00
QUICK RATIO (ACID-TEST) AVG TTM
N/A
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+437.40%
vs the sector median at left
Seaport Therapeutics, Inc. Common Stock
Market Cap
$942.38M
Quick Ratio (Acid-Test)
18.00
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$938.35M
Quick Ratio (Acid-Test)
4.71
TTM Avg
7.76
3Y Avg
11.58
5Y Avg
15.68
Market Cap
$935.90M
Quick Ratio (Acid-Test)
8.79
TTM Avg
12.77
3Y Avg
8.84
5Y Avg
8.84
Market Cap
$953.94M
Quick Ratio (Acid-Test)
10.13
TTM Avg
12.79
3Y Avg
15.72
5Y Avg
14.10
Market Cap
$930.32M
Quick Ratio (Acid-Test)
12.56
TTM Avg
15.19
3Y Avg
22.99
5Y Avg
17.56
Market Cap
$969.98M
Quick Ratio (Acid-Test)
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$912.83M
Quick Ratio (Acid-Test)
1.06
TTM Avg
1.14
3Y Avg
1.09
5Y Avg
1.06
Market Cap
$976.29M
Quick Ratio (Acid-Test)
3.94
TTM Avg
2.64
3Y Avg
3.04
5Y Avg
2.66
Market Cap
$899.69M
Quick Ratio (Acid-Test)
1.17
TTM Avg
1.03
3Y Avg
0.92
5Y Avg
1.05
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. Common Stock (SPTX) | $942.38M | 18.00 | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $938.35M | 4.71 | 7.76 | 11.58 | 15.68 |
| CeriBell, Inc. (CBLL)vs › | $935.90M | 8.79 | 12.77 | 8.84 | 8.84 |
| Savara Inc. (SVRA)vs › | $953.94M | 10.13 | 12.79 | 15.72 | 14.10 |
| MoonLake Immunotherapeutics (MLTX)vs › | $930.32M | 12.56 | 15.19 | 22.99 | 17.56 |
| Aktis Oncology, Inc. (AKTS)vs › | $969.98M | 16.33 | 11.68 | 16.13 | 16.13 |
| HealthStream, Inc. (HSTM)vs › | $912.83M | 1.06 | 1.14 | 1.09 | 1.06 |
| Pacira BioSciences, Inc. (PCRX)vs › | $976.29M | 3.94 | 2.64 | 3.04 | 2.66 |
| Bioventus Inc. (BVS)vs › | $899.69M | 1.17 | 1.03 | 0.92 | 1.05 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $987.62M | 15.08 | 22.50 | 27.08 | 27.08 |
Quick Ratio
18.00
Excludes inventory
Current Ratio
18.00
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 18.00 |
| 2026-03-31 | 13.24 |
